AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Elbit Imaging-M Ltd.

Earnings Release May 31, 2016

6760_rns_2016-05-31_39773d52-76ea-4d8d-bd3e-1fcf20511a08.pdf

Earnings Release

Open in Viewer

Opens in native device viewer

ELBIT IMAGING LTD. ANNOUNCES FIRST QUARTER RESULTS FOR 2016

Tel Aviv, Israel, May 31, 2016, Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) ("Elbit"" or the "Company") announced today its results for the first quarter of 2016.

Three months ended March 31, 2016 compared to corresponding period in 2015:

The Company's loss for the three months period ended March 31, 2016 ("Q1 2016") amounted to NIS 65 million (US\$ 17 million), compared to NIS 130 million in the corresponding period in 2015.

Consolidated revenues and gains for Q1 2016 amounted to NIS 98 million (US\$ 26 million) compared to NIS 67 million in the corresponding period in 2015 ("Q1 2015").

  • Revenues from sale of commercial centers amounted to 47 million in Q1 2016 compared to nil in Q1 2015. Such revenues in Q1 2016 was mainly attributable to the sale of Liberec Plaza commercial centers in Czech Republic by our 44.9% subsidiary, Plaza Centers N.V. ("PC"), and the sale of plots in Romania and Poland by PC.
  • Rental income from commercial centers decreased in Q1 2016 to NIS 19 million (US\$ 5 million) compared to NIS 24 million in Q1 2015. The decrease was mainly attributable to (i) decrease in income from Koregaon commercial center which was sold in May 2015 (ii) decreases in revenues from the entertainment parks within the commercial centers (iii) decrease in the same commercial centers rental income.
  • Cost of commercial centers increased in Q1 2016 to NIS 60 million (US\$ 16 million) compared to NIS 18 million in Q1 2015. The increase attributable to cost of the commercial centers and the Plots sold during Q1 2016 in the total amount of NIS 47 million compared to nil in Q1 2015 partially offset by decrease in operational expenses of the commercial centers from NIS 18 million in Q1 2015 to NIS 13 million in Q1 2016.
  • Revenues from hotels operation and management in Q1 2016 amounted to NIS 31 million (US\$ 8 million) compared to NIS 43 million in Q1 2015. The decrease was mainly attributable to the sale of our hotels in Antwerp, Belgium in June 2015 offset by an increase in the revenue of the Radisson Blu Hotel in Bucharest Romania.
  • Costs and expenses of hotels operation and management decreased in Q1 2016 to NIS 28 million (US\$ 7 million) compared to NIS 39 million in Q1 2015. The decrease resulted from the decrease in the revenue as mentioned above.
  • General and administrative expenses amounted to NIS 3 million (US\$ 1 million) in Q1 2016 compared to NIS 4 million in Q1 2015. The decrease in mainly attributable to efficiency measures taken by the Company reducing the general and administrative costs in the Company's headquarters.

  • Share in losses of associates, net amounted to NIS 11 million (US\$ 3 million) in Q1 2016 compared to NIS 14 million in Q1 2015. Such losses were mainly attributable to our share in the losses of our Medical portfolio companies, InSightec Ltd and Gamida Cell Ltd.

  • Financial expenses, net decreased in Q1 2016 to NIS 59 million (US\$ 16 million) compared to NIS 124 million in Q1 2015. The decrease of NIS 65 million is mainly attributable to the following:
    • o A decrease in the amount of NIS 90 million (US\$ 24 million) in exchange rate losses mainly with respect to PC's debentures linked to NIS and measured in Euro as a result of devaluation of the EURO against the NIS in 0.9% in Q1 2016 compared to a devaluation of 9.5% in Q1 2015; Offset by:
    • o An increase in interest expenses in the amount of NIS 25 million (US\$ 7 million) mainly attributable to increase in the PC's interest due to highly effective interest rates on PC's debentures and an acceleration of discount amortization offset by a decrease in PC's interest on bank loans due to the sale of commercial centers during 2015.
  • Other expenses, net in Q1 2016 amounted to NIS 1 million (US\$ 0.2 million) compared to NIS 2 million in Q1 2015.
  • Loss before tax expenses amounted to NIS 64 million (US\$ 17 million) in Q1 2016 compared to NIS 134 million in Q1 2015.
  • Tax expenses amounted to NIS 1 million (US\$ 0.4 million) in Q1 2016 compared to of NIS 2 million in Q1 2015.
  • Loss from continuing operations amounted to NIS 65 million (US\$ 17 million) in Q1 2016 compared to NIS 137 million in Q1 2015.
  • Profit from discontinued operations, net, amounted to nil Q1 2016 compared to NIS 7 million in Q1 2015. The profit in Q1 2015 was mainly attributed to the Company's fashion retail operation which was sold during Q1 2015, and accordingly reclassified as discontinued operations.
  • Loss for Q1 2016 amounted to NIS 65 million (US\$ 17 million) (out of which NIS 45 million is attributed to the equity holders of the Company) compared to NIS 130 million in the corresponding period in 2015 (out of which NIS 83 million is attributed to the equity holders of the Company).
  • Shareholders' equity/Deficiency as of March 31, 2016 amounted to NIS 242 million (\$ 64 million) (out of which Shareholders' deficiency in the amount of NIS 23 million (\$ 6 million) is attributed to the controlling interest). The decrease in the shareholder's equity results mainly from the loss for the period.

About Elbit Imaging Ltd.

Elbit Imaging Ltd. operates in the following principal fields of business: (i) Commercial centers - initiation, construction, and sale of commercial centers and other mixed-use property projects, predominantly in the retail sector, located in Central and Eastern Europe. In certain circumstances and depending on market conditions, the Group operates and manages commercial centers prior to their sale. (ii) Hotel - operation and management of the Radisson hotel Complex in Bucharest, Romania. (iii) Medical industries and devices - (a) research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment, and (b) development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine. (iv) Plots in India - plots designated for sale initially designated to residential projects.

Any forward-looking statements in our releases include statements regarding the intent, belief or current expectations of Elbit Imaging Ltd. and our management about our business, financial condition, results of operations, and its relationship with its employees and the condition of our properties. Words such as "believe," "expect," "intend," "estimate" and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Actual results may differ materially from those projected, expressed or implied in the forward-looking statements as a result of various factors including, without limitation, a change in market conditions, a decision to deploy the cash for other business opportunities and the factors set forth in our filings with the Securities and Exchange Commission including, without limitation, Item 3.D of our annual report on Form 20-F for the fiscal year ended December 31, 2015, under the caption "Risk Factors." Any forward-looking statements contained in our releases speak only as of the date of such release, and we caution existing and prospective investors not to place undue reliance on such statements. Such forwardlooking statements do not purport to be predictions of future events or circumstances, and therefore, there can be no assurance that any forward-looking statement contained in our releases will prove to be accurate. We undertake no obligation to update or revise any forward-looking statements.

For Further Information: Company Contact Ron Hadassi Chairman of the Board of Directors Tel: +972-3-608-6048 Fax: +972-3-608-6050 [email protected]

ELBIT IMAGING LTD. CONSOLIDATED BALANCE SHEETS

March 31 December 31 March 31
2 0 1 6 2 0 1 5 2 0 16
Convenience
translation
(in NIS thousands) US\$'000
Current Assets
Cash and cash equivalents 143,976 157,851 38,231
Short-term deposits and investments 32,368 30,075 8,595
Trade accounts receivables 53,524 13,638 14,212
Other receivables 17,137 13,909 4,550
Inventories 1,934 2,071 514
248,939 217,544 66,102
Non-Current Assets
Trading property 1,443,484 1,467,760 383,294
Deposits, loans and other long-term balances 32,398 21,899 8,603
Investments in associates 274,545 292,183 72,901
Property, plant and equipment 710,316 704,166 188,613
2,460,743 2,486,008 653,410
2,709,682 2,703,552 719,512
Current Liabilities
Short-term credits 511,057 726,763 135,703
Suppliers and service providers 17,124 15,708 4,547
Payables and other credit balances 66,376 63,780 17,624
594,557 806,251 157,874
Non-Current liabilities
Borrowings 1,720,470 1,443,920 456,843
Other liabilities 67,388 66,530 17,894
Deferred taxes 85,079 82,787 22,591
1,872,937 1,593,237 497,328
Shareholders' Equity (Deficiency)
Attributable to equity holders of the Company (23,035) 19,287 (6,116)
Non-controlling Interests 265,223 284,777 70,426
242,188 304,064 64,310
2,709,682 2,703,552 719,512

ELBIT IMAGING LTD. CONSOLIDATED INCOME STATEMENTS

Three months ended
March 31
Year ended
December 31,
Three
months
ended
March 31
2 0 1 6 2 0 1 5 2 0 1 5 2 0 1 6
Convenience
translation
(in NIS thousands) US\$'000
Revenues and gains
Revenues
Revenues from sale of commercial centers
47,400 - 200,078 12,586
Revenues from hotel operation and
management 30,778 42,889 147,886 8,173
Total revenues 78,178 42,889 347,964 20,759
Gains and other
Gain from sale of investees - - 6,712 -
Rental income from Commercial centers 19,479 24,554 83,849 5,172
Total gains 19,479 24,554 90,561 5,172
Total revenues and gains 97,657 67,443 438,525 25,931
Expenses and losses
Commercial centers 60,171 17,954 290,360 15,977
Hotels operations and management 28,069 39,471 126,849 7,453
General and administrative expenses 2,597 4,204 16,678 690
Share in losses of associates, net
Financial expenses, net
10,900
58,898
14,274
124,089
42,925
239,580
2,894
15,639
Write-down, charges and other expenses, net 782 1,904 38,298 208
161,417 201,896 754,690 42,861
Loss before income taxes )63,760( )134,453( (316,165) (16,930)
Income tax expenses 1,409 2,267 5,631 374
Loss from continuing operations )65,169( )136,720( (321,796) (17,304)
Profit from discontinued operation, net - 6,832 6,874 -
Loss for the period )65,169( )129,888( (314,922) )17,304(
Attributable to:
Equity holders of the Company )45,550( )83,072( (186,150) (12,095)
Non-controlling interest )19,619( )46,816( (128,772) (5,209)
)65,169( )129,888( (314,922) (17,304)

ELBIT IMAGING LTD. CONSOLIDATED COMPREHENSIVE INCOME STATEMENTS

Three months ended
March 31
Year ended
December 31,
Three
months
ended
March 31
2 0 1 6 2 0 1 5 2 0 1 5 2 0 1 6
Convenience
translation
(in NIS thousands) US\$'000
Loss for the period )65,169( )129,888( (314,922) (17,304)
Other comprehensive income to be
reclassified to profit or loss in subsequent
periods:
Exchange differences arising from translation of
foreign operations
1,668 (62,130) (91,319) 450
Gain (loss) from cash flow hedge
Reclassification adjustments relating to foreign
821 (52) 2,081 213
operations disposed of in the year - - (32,454) -
2,489 )62,182( (121,692) 663
Items not to be reclassified to profit or loss in
subsequent periods:
Additions during the year 794 - 83,582 206
794 - 83,582 206
Other Comprehensive income (loss) 3,283 )62,182( (38,110) 869
Comprehensive Loss )61,886( )192,070( (353,032) )16,435(
Attributable to:
Equity holders of the Company
Non-controlling interest
(42,322)
(19,564)
(119,105)
(72,965)
(206,504)
(146,528)
(11,240)
(5,195)
(61,886) (192,070) (353,032) (16,435)

ELBIT IMAGING LTD. STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY

Share
capital
Share
premium
Other
reserves (*)
Revaluation
of property,
plant and
equipment
Stock
based
compens
ation
reserve
Foreign
currency
translation
reserve
Retained
earnings
Gross
amount
Treasury
stock
Attributable
to
shareholders
of the
company
Non
Controlling
interest
Total
shareholder
s' equity
(in thousand NIS)
Balance -
January 1, 2015 - 1,055,056 (201,848) 130,549 49,527 (734,176) (67,129) 231,979 - 231,979 481,258 713,237
Lloss
for the year
- - - - - - (186,150) (186,150) - (186,150) (128,772) (314,922)
Other comprehensive
income (loss) - - 8,007 60,783 - (109,649) 20,504 (20,355) - (20,355) (17,756) (38,111)
Stock based
compensation
expenses - - - - 845 - - 845 - 845 (175) 670
Transaction with non
controlling interest - - (148,066) 37,413 - 94,933 8,142 (7,578) - (7,578) (50,565) (58,143)
Expiration of options
held by minority
Cancelation of treasury
- - - - 546 546 546 787 1,333
stock and old stock - 50,918 - - (50,918) - - - - - - -
Balance -
December 31, 2015 - 1,105,974 (341,907) 228,745 - (748,892) (224,633) 19,287 - 19,287 284,777 304,064
Loss
for the year
- - - - - - (45,550) (45,550) - (45,550) (19,619) (65,169)
Other comprehensive
income (loss) - - 803 (2,457) - 1,648 3,234 3,228 - 3,228 55 3,283
Stock based
compensation
expenses - - - - - - - - - - 10 10
Balance -
March 31, 2016 - 1,105,974 (341,104) 226,288 - (747,244) (266,949) (23,035) - (23,035) 265,223 242,188

(*) includes transactions with non-controlling interest reserve and hedging reserve.

ELBIT IMAGING LTD. STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY

Share
capital
Share
premium
Other
reserves (*)
Revaluation
of property,
plant and
equipment
Stock-based
compensati
on reserve
Foreign
currency
translation
reserve
Convenience translation, U.S.\$'000
Retained
earnings
Gross
amount
Treasury
stock
Attributable
to share
holders of
the company
Non
Controlling
interest
Total
shareholder's
equity
Balance -
December 31, 2015
- 293,673 )90,788( 60,740 - (198,861) (59,642) 5,122 - 5,122 75,618 80,739
Loss
for the year
Other comprehensive
- - - - - - (12,095) (12,095) - (12,095) (5,209) (17,304)
income (loss)
Stock based
compensation
- - 213 (652) - 438 859 857 - 857 14 871
expenses - - - - - - - - - - 3 3
Balance -
March 31, 2016
- 293,673 (90,574) 60,087 - (198,423) (70,879) (6,116) - (6,116) 70,426 64,310

(*) includes transactions with non-controlling interest reserve and hedging reserve.

Talk to a Data Expert

Have a question? We'll get back to you promptly.